Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation.

Naumann, Patrick; Eberlein, Jonathan; Farnia, Benjamin; Hackert, Thilo; Debus, Jürgen; Combs, Stephanie E

Naumann, Patrick; Eberlein, Jonathan; Farnia, Benjamin; Hackert, Thilo; Debus, Jürgen; Combs, Stephanie E.

Afiliação

Naumann P; Department of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. patrick.naumann@med.uni-heidelberg.de.
Eberlein J; Clinical Cooperation Unit Radiation Oncology, dkfz Heidelberg, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. patrick.naumann@med.uni-heidelberg.de.
Farnia B; Department of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. jonathan.eberlein@med.uni-heidelberg.de.
Hackert T; Department of Radiation Oncology, University of Miami, 1475 NW 12th Avenue, Suite 1500, Miami, FL 33136, USA. benjamin.farnia@jhsmiami.org.
Debus J; Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany. thilo.hackert@med.uni-heidelberg.de.
Combs SE; Department of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. juergen.debus@med.uni-heidelberg.de.

Cancers (Basel) ; 11(5)2019 May 23.

Article em En | MEDLINE | ID: mdl-31126040

Palavras-chave

body composition; cachexia; chemoradiation; locally advanced pancreatic cancer; muscle wasting; sarcopenia; skeletal muscle index; weight loss

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google